SG10201913868XA - T cell receptors recognizing hla-cw8 restricted mutated kras - Google Patents
T cell receptors recognizing hla-cw8 restricted mutated krasInfo
- Publication number
- SG10201913868XA SG10201913868XA SG10201913868XA SG10201913868XA SG10201913868XA SG 10201913868X A SG10201913868X A SG 10201913868XA SG 10201913868X A SG10201913868X A SG 10201913868XA SG 10201913868X A SG10201913868X A SG 10201913868XA SG 10201913868X A SG10201913868X A SG 10201913868XA
- Authority
- SG
- Singapore
- Prior art keywords
- cell receptors
- mutated kras
- receptors recognizing
- recognizing hla
- restricted
- Prior art date
Links
- 108091008874 T cell receptors Proteins 0.000 title 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562218688P | 2015-09-15 | 2015-09-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201913868XA true SG10201913868XA (en) | 2020-03-30 |
Family
ID=56985686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201913868XA SG10201913868XA (en) | 2015-09-15 | 2016-09-09 | T cell receptors recognizing hla-cw8 restricted mutated kras |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10556940B2 (en) |
| EP (2) | EP3901169A1 (en) |
| JP (2) | JP7185524B2 (en) |
| KR (1) | KR20180044428A (en) |
| CN (2) | CN115073583A (en) |
| AU (3) | AU2016323017B2 (en) |
| CA (1) | CA2998869A1 (en) |
| DK (1) | DK3350213T3 (en) |
| ES (1) | ES2879287T3 (en) |
| HK (1) | HK1257902A1 (en) |
| IL (1) | IL257840B2 (en) |
| MX (1) | MX2018003062A (en) |
| SA (1) | SA518391109B1 (en) |
| SG (1) | SG10201913868XA (en) |
| WO (1) | WO2017048593A1 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2595063B (en) | 2015-07-31 | 2022-03-09 | Univ Minnesota | Modified cells and methods of therapy |
| PT3494133T (en) * | 2016-08-02 | 2022-09-28 | Us Health | Anti-kras-g12d t cell receptors |
| GB201700621D0 (en) | 2017-01-13 | 2017-03-01 | Guest Ryan Dominic | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue |
| CN110612446B (en) * | 2017-03-31 | 2023-07-04 | 美国卫生和人力服务部 | Method for isolating novel antigen-specific T cell receptor sequences |
| EP3635000A4 (en) * | 2017-05-16 | 2021-04-14 | The Johns Hopkins University | Manabodies and methods of using |
| EP3645021A4 (en) | 2017-06-30 | 2021-04-21 | Intima Bioscience, Inc. | Adeno-associated viral vectors for gene therapy |
| JP7256794B2 (en) | 2017-09-20 | 2023-04-12 | アメリカ合衆国 | HLA class II restricted T-cell receptor for mutant RAS |
| JP7385566B2 (en) | 2017-12-04 | 2023-11-22 | アメリカ合衆国 | HLA class I-restricted T cell receptor for mutant RAS |
| SG11202012653XA (en) * | 2018-06-19 | 2021-01-28 | Biontech Us Inc | Neoantigens and uses thereof |
| EP3837279A4 (en) * | 2018-08-16 | 2022-05-11 | BioNTech US Inc. | T cell receptor constructs and uses thereof |
| CN113412277A (en) * | 2019-01-22 | 2021-09-17 | 美国卫生和人力服务部 | HLA class II restricted T cell receptor for RAS containing G12R mutation |
| CA3130618A1 (en) | 2019-02-20 | 2020-08-27 | Fred Hutchinson Cancer Research Center | Binding proteins specific for ras neoantigens and uses thereof |
| WO2020210202A1 (en) * | 2019-04-11 | 2020-10-15 | The Board Of Trustees Of The Leland Stanford Junior University | Cytotoxic t lymphocytes specific for mutated forms of epidermal growth factor receptor for use in treating cancer |
| CN110172089B (en) * | 2019-06-11 | 2020-01-07 | 北京鼎成肽源生物技术有限公司 | KRAS mutant multi-antigen combination, targeting KRAS mutant tumor CTL and application thereof |
| CN112110995A (en) * | 2019-06-19 | 2020-12-22 | 上海交通大学医学院 | Tumor neoantigen polypeptide and application thereof |
| CN112759641B (en) * | 2019-11-01 | 2023-01-20 | 香雪生命科学技术（广东）有限公司 | High-affinity TCR for recognizing Kras G12V |
| JP2023507432A (en) | 2019-12-20 | 2023-02-22 | インスティル バイオ （ユーケイ） リミテッド | Devices and methods for isolating tumor-infiltrating lymphocytes and uses thereof |
| CN111574616B (en) * | 2020-06-17 | 2021-02-02 | 深圳豪石生物科技有限公司 | Isolated T cell receptors and uses |
| AU2022227085A1 (en) | 2021-02-25 | 2023-09-14 | Alaunos Therapeutics, Inc. | Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof |
| WO2023150562A1 (en) | 2022-02-01 | 2023-08-10 | Alaunos Therapeutics, Inc. | Methods for activation and expansion of t cells |
| CN114920824B (en) * | 2022-05-27 | 2023-12-05 | 重庆医科大学 | TCR or antigen binding fragment thereof and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1545204T3 (en) | 2002-09-06 | 2016-11-14 | The Government Of The Us Secretary Dept Of Health And Human Services | Immunotherapy with in vitro selected antigen-specific lymphocytes following non-myeloablative lymphodepletive chemotherapy |
| JP5079697B2 (en) * | 2005-08-05 | 2012-11-21 | ヘルムホルツ ツェントラム ミュンヘン ドイチェス フォーシュングスツェントラム フュール ゲズントハイト ウント ウンヴェルト ゲーエムベーハー | Method for generating antigen-specific T cells |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| CN110951690A (en) | 2010-09-20 | 2020-04-03 | 生物技术细胞和基因治疗公司 | Antigen-specific T cell receptors and T cell epitopes |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| WO2013039889A1 (en) | 2011-09-15 | 2013-03-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors recognizing hla-a1- or hla-cw7-restricted mage |
| GB201314404D0 (en) | 2013-08-12 | 2013-09-25 | Immunocore Ltd | T Cell Receptors |
| JP6863893B2 (en) | 2014-11-26 | 2021-04-21 | アメリカ合衆国 | Anti-mutant KRAS T cell receptor |
-
2016
- 2016-09-09 CN CN202111083392.9A patent/CN115073583A/en active Pending
- 2016-09-09 AU AU2016323017A patent/AU2016323017B2/en active Active
- 2016-09-09 DK DK16770408.9T patent/DK3350213T3/en active
- 2016-09-09 JP JP2018513423A patent/JP7185524B2/en active Active
- 2016-09-09 KR KR1020187010326A patent/KR20180044428A/en not_active Application Discontinuation
- 2016-09-09 WO PCT/US2016/050875 patent/WO2017048593A1/en active Application Filing
- 2016-09-09 CN CN201680058891.3A patent/CN108350059B/en active Active
- 2016-09-09 CA CA2998869A patent/CA2998869A1/en active Pending
- 2016-09-09 EP EP21162567.8A patent/EP3901169A1/en active Pending
- 2016-09-09 EP EP16770408.9A patent/EP3350213B1/en active Active
- 2016-09-09 IL IL257840A patent/IL257840B2/en unknown
- 2016-09-09 ES ES16770408T patent/ES2879287T3/en active Active
- 2016-09-09 SG SG10201913868XA patent/SG10201913868XA/en unknown
- 2016-09-09 US US15/758,954 patent/US10556940B2/en active Active
- 2016-09-09 MX MX2018003062A patent/MX2018003062A/en unknown
-
2018
- 2018-03-13 SA SA518391109A patent/SA518391109B1/en unknown
-
2019
- 2019-01-08 HK HK19100263.9A patent/HK1257902A1/en unknown
-
2020
- 2020-01-10 US US16/739,310 patent/US11667692B2/en active Active
-
2021
- 2021-02-10 AU AU2021200833A patent/AU2021200833B2/en active Active
-
2022
- 2022-07-26 AU AU2022209229A patent/AU2022209229B2/en active Active
- 2022-11-25 JP JP2022188263A patent/JP7461445B2/en active Active
-
2023
- 2023-05-01 US US18/310,141 patent/US20230406904A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7185524B2 (en) | 2022-12-07 |
| IL257840B2 (en) | 2023-10-01 |
| AU2022209229B2 (en) | 2024-05-23 |
| KR20180044428A (en) | 2018-05-02 |
| CN108350059B (en) | 2021-10-08 |
| AU2021200833B2 (en) | 2022-04-28 |
| AU2022209229A1 (en) | 2022-09-15 |
| MX2018003062A (en) | 2018-09-11 |
| DK3350213T3 (en) | 2021-06-21 |
| US20190040111A1 (en) | 2019-02-07 |
| US11667692B2 (en) | 2023-06-06 |
| ES2879287T3 (en) | 2021-11-22 |
| US10556940B2 (en) | 2020-02-11 |
| AU2016323017A1 (en) | 2018-04-05 |
| CA2998869A1 (en) | 2017-03-23 |
| JP2023025108A (en) | 2023-02-21 |
| EP3901169A1 (en) | 2021-10-27 |
| WO2017048593A1 (en) | 2017-03-23 |
| IL257840B1 (en) | 2023-06-01 |
| US20230406904A1 (en) | 2023-12-21 |
| CN108350059A (en) | 2018-07-31 |
| AU2016323017B2 (en) | 2020-11-12 |
| AU2021200833A1 (en) | 2021-03-04 |
| US20200148739A1 (en) | 2020-05-14 |
| EP3350213B1 (en) | 2021-03-31 |
| IL257840A (en) | 2018-04-30 |
| EP3350213A1 (en) | 2018-07-25 |
| HK1257902A1 (en) | 2019-11-01 |
| JP7461445B2 (en) | 2024-04-03 |
| SA518391109B1 (en) | 2022-02-14 |
| JP2018535647A (en) | 2018-12-06 |
| CN115073583A (en) | 2022-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1257902A1 (en) | T cell receptors recognizing hla-cw8 restricted mutated kras | |
| HK1243642A1 (en) | Anti-mutated kras t cell receptors | |
| IL262144A (en) | T cell receptors | |
| ZA201806866B (en) | T cell receptors | |
| ZA201806862B (en) | T cell receptors | |
| ZA201806865B (en) | T cell receptors | |
| IL264425B1 (en) | Anti-kras-g12d t cell receptors | |
| IL251524A0 (en) | T cell receptors | |
| GB201522592D0 (en) | T cell receptors | |
| LT3433270T (en) | T cell receptors | |
| GB201518991D0 (en) | T cell receptors |